October 29, 2018 Atomic Spectroscopy Clinical Research/Diagn. Life Science Tools Microscopy

QIAGEN expands next-generation sequencing portfolio with oncology and immuno-oncology panels for research using GeneReader NGS System and other platforms 

Hilden, Germany, and Germantown, Maryland, October 29, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of three innovative Sample to Insight workflows for next-generation sequencing (NGS) research in oncology using QIAGEN’s GeneReader NGS System and other NGS platforms. QIAGEN is introducing the novel NGS workflows for clinical research in... Read more

October 23, 2018 Life Science Tools M&A, Partnerships

Lexogen supports thousands of RNA researchers worldwide by partnering with the RNA Society in their 2018/19 RNA Salon initiative

Vienna, Austria, October 23, 2018 /PRNewswire/ – RNA (ribonucleic acid) is one of the most important building blocks of life, and this molecule is researched in diverse biological disciplines. In 2016, the RNA Society launched the “RNA Salon” program to cultivate interactions between RNA researchers who might be regionally close but belong to various departments or... Read more

October 22, 2018 Environ, Ag./Food & Bev Informatics & Software Life Science Tools M&A, Partnerships

NRGene and Kayagene, LLC Collaborate to Improve Cannabis Breeding and Seed Production

Revealing the complete genome makeup of multiple varieties resolves the genetic basis of key traits Ness Ziona, Israel, and Salinas, Calif. (Oct 22, 2018)– Kayagene, an innovative cannabis breeding company, and NRGene, the leading agricultural genomics company, are collaborating on research to enhance Kayagene’s breeding capabilities  to develop improved cannabis varieties and more robust seed production. The non-exclusive... Read more

October 18, 2018 Life Science Tools PR/Corporate

Amgen invests £50 million ($66 million) in Oxford Nanopore Technologies

Thu 18th October 2018 THOUSAND OAKS, Calif. and OXFORD, England – (Oct. 18, 2018) – Amgen (NASDAQ:AMGN) and Oxford Nanopore Technologies Ltd. today announced Amgen’s equity investment of £50 million ($66 million) in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology. Oxford Nanopore has developed and brought to... Read more

October 18, 2018 Life Science Tools

LGC announces new name for integrated genomics brand, Biosearch Technologies

18 OCT 2018 Tags:  Genomics LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes. Biosearch Technologies will focus on further developing its capabilities in NGS and Nucleic Acid Chemistry, which build on expertise in existing genomic analysis... Read more

October 18, 2018 Informatics & Software Life Science Tools M&A, Partnerships

Fabric Genomics and Genomenon Sign Partnership Agreement to Speed Genomic Interpretation

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. and ANN ARBOR, Michigan, October 18, 2018 – Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further... Read more

October 16, 2018 Life Science Tools Product Launch

10x Genomics Showcases New Solutions at ASHG 2018

Introduces significant advances to its flagship Single Cell Gene Expression Solution   PLEASANTON, CA.—October 16, 2018—10x Genomics, a leader in the genomics field, today announced the commercial availability of new solutions and technology that will significantly impact the future of genomic research by moving toward single cell multi-omics analysis. The new solutions will be showcased... Read more

October 16, 2018 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Product Launch

BD Launches Molecular Test For Detecting Tuberculosis And Multi-Drug Resistant TB

BD MAX™ MDR-TB Panel Obtains CE-IVD Status in Europe FRANKLIN LAKES, N.J., Oct. 16, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX™ MDR-TB panel in Europe. Clinicians can use the test to simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria... Read more

October 16, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population FinnGen, a first-of-its-kind study of 500,000 individuals, combines genomics and health record data to better understand disease origins and improve human health SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced facilitation of the next phase of the FinnGen precision... Read more

October 15, 2018 Clinical Research/Diagn. Life Science Tools PR/Corporate

NanoString Announces $100 Million Term Loan Facility with CRG

October 15, 2018 09:00 ET | Source: NanoString Technologies, Inc. SEATTLE, Oct. 15, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P. (CRG), a health care focused... Read more